GB0127349D0 - Macrolides - Google Patents

Macrolides

Info

Publication number
GB0127349D0
GB0127349D0 GBGB0127349.9A GB0127349A GB0127349D0 GB 0127349 D0 GB0127349 D0 GB 0127349D0 GB 0127349 A GB0127349 A GB 0127349A GB 0127349 D0 GB0127349 D0 GB 0127349D0
Authority
GB
United Kingdom
Prior art keywords
macrolides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0127349.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Pliva Farmaceutika dd
Original Assignee
Glaxo Group Ltd
Pliva Farmaceutika dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Farmaceutika dd filed Critical Glaxo Group Ltd
Priority to GBGB0127349.9A priority Critical patent/GB0127349D0/en
Publication of GB0127349D0 publication Critical patent/GB0127349D0/en
Priority to UA20040503313A priority patent/UA77210C2/uk
Priority to PL02371472A priority patent/PL371472A1/xx
Priority to AT02779670T priority patent/ATE362479T1/de
Priority to HU0402225A priority patent/HUP0402225A3/hu
Priority to US10/495,413 priority patent/US7202221B2/en
Priority to EP02779670A priority patent/EP1453846B1/en
Priority to CA002466975A priority patent/CA2466975A1/en
Priority to CNB028270452A priority patent/CN1307194C/zh
Priority to JP2003544063A priority patent/JP2005515978A/ja
Priority to DE60220180T priority patent/DE60220180T2/de
Priority to ES02779670T priority patent/ES2287332T3/es
Priority to HR20040433A priority patent/HRP20040433A2/hr
Priority to YU41904A priority patent/RS41904A/sr
Priority to PCT/GB2002/005101 priority patent/WO2003042228A1/en
Priority to IL16171002A priority patent/IL161710A0/xx
Priority to ARP020104364A priority patent/AR037371A1/es
Priority to BR0214132-9A priority patent/BR0214132A/pt
Priority to EA200400536A priority patent/EA007433B1/ru
Priority to ZA200403684A priority patent/ZA200403684B/xx
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
GBGB0127349.9A 2001-11-14 2001-11-14 Macrolides Ceased GB0127349D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
EA200400536A EA007433B1 (ru) 2001-11-14 2002-11-13 Макролиды
CNB028270452A CN1307194C (zh) 2001-11-14 2002-11-13 大环内酯类化合物
DE60220180T DE60220180T2 (de) 2001-11-14 2002-11-13 14 bis 15 gliedrige makrolide mit antibakterieller aktivität
AT02779670T ATE362479T1 (de) 2001-11-14 2002-11-13 14 bis 15 gliedrige makrolide mit antibakterieller aktivität
HU0402225A HUP0402225A3 (en) 2001-11-14 2002-11-13 Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
US10/495,413 US7202221B2 (en) 2001-11-14 2002-11-13 Macrolides
EP02779670A EP1453846B1 (en) 2001-11-14 2002-11-13 14 or 15 membered macrolides with antibacterial activity
CA002466975A CA2466975A1 (en) 2001-11-14 2002-11-13 Macrolides
UA20040503313A UA77210C2 (en) 2001-11-14 2002-11-13 Macrolids, process for their manufacture (variants), pharmaceutical composition, method for treatment of bacterial infections
JP2003544063A JP2005515978A (ja) 2001-11-14 2002-11-13 マクロライド
PL02371472A PL371472A1 (en) 2001-11-14 2002-11-13 Macrolides
ES02779670T ES2287332T3 (es) 2001-11-14 2002-11-13 Macrolidos de 14 o 15 miembros con actividad antibacteriana.
HR20040433A HRP20040433A2 (en) 2001-11-14 2002-11-13 Macrolides
YU41904A RS41904A (sr) 2001-11-14 2002-11-13 Makrolidi
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides
IL16171002A IL161710A0 (en) 2001-11-14 2002-11-13 Macrolides
ARP020104364A AR037371A1 (es) 2001-11-14 2002-11-13 Compuesto macrolida, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamento
BR0214132-9A BR0214132A (pt) 2001-11-14 2002-11-13 Composto, processo para a preparação e uso do mesmo, composição farmacêutica, e, método para o tratamento do organismo animal humano ou não humano para combater infecção bacteriana
ZA200403684A ZA200403684B (en) 2001-11-14 2004-05-13 Macrolides.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides

Publications (1)

Publication Number Publication Date
GB0127349D0 true GB0127349D0 (en) 2002-01-02

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0127349.9A Ceased GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides

Country Status (20)

Country Link
US (1) US7202221B2 (enExample)
EP (1) EP1453846B1 (enExample)
JP (1) JP2005515978A (enExample)
CN (1) CN1307194C (enExample)
AR (1) AR037371A1 (enExample)
AT (1) ATE362479T1 (enExample)
BR (1) BR0214132A (enExample)
CA (1) CA2466975A1 (enExample)
DE (1) DE60220180T2 (enExample)
EA (1) EA007433B1 (enExample)
ES (1) ES2287332T3 (enExample)
GB (1) GB0127349D0 (enExample)
HR (1) HRP20040433A2 (enExample)
HU (1) HUP0402225A3 (enExample)
IL (1) IL161710A0 (enExample)
PL (1) PL371472A1 (enExample)
RS (1) RS41904A (enExample)
UA (1) UA77210C2 (enExample)
WO (1) WO2003042228A1 (enExample)
ZA (1) ZA200403684B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7022679B2 (en) 2002-05-13 2006-04-04 Enanta Pharmaceuticals, Inc. Processes for the preparation of 6-11 bicyclic erythromycin derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
EP1503759B1 (en) * 2002-05-14 2008-12-17 The Regents Of The University Of California Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
EP1628989B1 (en) * 2003-05-13 2006-12-20 Glaxo Group Limited Novel 14 and 15 membered-ring compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
AU2005240849B2 (en) * 2004-05-06 2008-10-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
CA2566112A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Carbamate linked macrolides useful for the treatment of microbial infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
ES2428874T3 (es) * 2006-08-09 2013-11-12 Basilea Pharmaceutica Ag Nuevos macrólidos útiles contra las enfermedades inflamatorias y alérgicas
CN101541331A (zh) 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
US8410065B2 (en) 2008-02-08 2013-04-02 Basilea Pharmaceutica Ag Macrolides and their use
EP2435460B1 (en) 2009-05-27 2015-01-07 Wockhardt Limited Ketolide compounds having antimicrobial activity
RU2601550C2 (ru) 2010-12-09 2016-11-10 Вокхардт Лимитед Кетолидные соединения
EP2671887A4 (en) * 2011-01-31 2014-06-25 Meiji Seika Pharma Co Ltd NEW MAKROLIDE DERIVATIVES
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
CN119060110A (zh) * 2023-05-30 2024-12-03 北京理工大学 一种红霉素衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
ES2252784T3 (es) 1996-05-07 2006-05-16 Abbott Laboratories Compuestos a base de eritromicina 6-0 sustituida y tecnica de produccion.
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
CA2380455C (en) 1999-08-24 2009-06-02 Abbott Laboratories 9a-azalides with antibacterial activity
WO2001063539A2 (en) 2000-02-24 2001-08-30 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6946446B2 (en) * 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
AR037371A1 (es) 2004-11-03
US7202221B2 (en) 2007-04-10
EA007433B1 (ru) 2006-10-27
ATE362479T1 (de) 2007-06-15
DE60220180D1 (de) 2007-06-28
HUP0402225A3 (en) 2006-01-30
IL161710A0 (en) 2004-09-27
US20050080025A1 (en) 2005-04-14
CN1307194C (zh) 2007-03-28
WO2003042228A1 (en) 2003-05-22
ZA200403684B (en) 2005-09-13
EP1453846B1 (en) 2007-05-16
BR0214132A (pt) 2004-09-14
CA2466975A1 (en) 2003-05-22
HRP20040433A2 (en) 2005-04-30
EA200400536A1 (ru) 2004-12-30
PL371472A1 (en) 2005-06-13
UA77210C2 (en) 2006-11-15
HUP0402225A2 (hu) 2005-02-28
RS41904A (sr) 2006-10-27
JP2005515978A (ja) 2005-06-02
CN1612888A (zh) 2005-05-04
DE60220180T2 (de) 2008-01-17
ES2287332T3 (es) 2007-12-16
EP1453846A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
IL161710A0 (en) Macrolides
DE50202400D1 (en) Baw-resonator
IL157974A0 (en) Pesticidal macrolides
AU2002360430A8 (en) 14-methyl-epothilones
HU0400176V0 (en) Improved gasketseal
GB0108534D0 (en) Retaining means
AU2002313943A8 (en) Electromobile
GB0108110D0 (en) Keeps
GB0127345D0 (en) Macrolides
GB0126277D0 (en) Macrolides
GB0127369D0 (en) Macrolides
GB0127352D0 (en) Macrolides
GB0127351D0 (en) Macrolides
GB2376939B (en) Retaining means
GB0025691D0 (en) Macrolides
GB0031306D0 (en) Macrolides
GB0025687D0 (en) Macrolides
GB0031309D0 (en) Macrolides
GB0031313D0 (en) Macrolides
GB0025689D0 (en) Macrolides
GB0025683D0 (en) Macrolides
GB0031311D0 (en) Macrolides
GB0025685D0 (en) Macrolides
GB0031314D0 (en) Macrolides
CA92665S (en) Bedboard

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)